Similar companies
Income Statement (CAD)
| Q2 '25 | QoQ | |
|---|---|---|
| Revenue | 71M | 7.9% |
| Gross Profit | 26M | 42% |
| Cost of Revenue | 45M | 5.4% |
| Operating expense | 28M | 8.7% |
| Net Income | -6.3M | 114.8% |
| EBITDA | 2.7M | 197.8% |
Balance Sheet (CAD)
| Q2 '25 | QoQ | |
|---|---|---|
| Total Assets | 565M | 5% |
| Total Liabilities | 179M | 21.6% |
| Total Equity | 385M | 1.3% |
| Shares Outstanding | 134M | 0.3% |
Cash Flow (CAD)
| Q2 '25 | QoQ | |
|---|---|---|
| Cash from operations | 15M | 188.2% |
| Cash from investing | -9.4M | 8.5% |
| Cash from financing | -560,000 | 101.4% |
Financial Highlights for Organigram in Q2 '25
Organigram reported a revenue of 71M, which is a 7.9% change from the previous quarter. An increase in revenue typically indicates growing demand for the company's products or services. This positive change in revenue is a good sign, suggesting that the company's sales are moving in the right direction.
Gross Profit stood at 26M, marking a 42% change since the last quarter. Gross profit showcases the efficiency in production and sales processes.
Cost of Revenue was 45M, a -5.4% difference from the previous quarter. A rising cost of revenue may suggest increased production or sales costs, which can impact margins. However, if accompanied by a proportionate rise in revenue, it could indicate scaling operations.
Operating Expenses for this period were 28M, showing a 8.7% change from the last quarter. Operating expenses cover the costs of running daily business operations. A significant increase might indicate inefficiencies or investments in growth, while a decrease could suggest cost-saving measures or potential underinvestment in key areas.
Net Income for the quarter was -6.3M, showing a -114.8% change from the prior quarter. Net income provides a clear picture of the company's profitability after all expenses. An increase suggests the company is becoming more profitable, while a decrease may raise concerns about the company's financial health, unless there are specific one-time costs or investments.
The company's EBITDA for the quarter was 2.7M, showing a 197.8% change from the previous period. EBITDA gives insight into the company's operational profitability, excluding non-operating expenses like interest and taxes. A rising EBITDA indicates strong operational performance, while a declining EBITDA may signal operational challenges or increased costs.
Organigram faced some challenges this quarter with a decline in one or more of the key metrics: revenue, gross profit, or net income. Higher operating expenses might indicate increased investments or potential inefficiencies.
